Lilly and Incyte Provide Update on Baricitinib
Go back to Lilly and Incyte Provide Update on Baricitinib| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 108.53 +0.70 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.83 | 52 Week High | $118.49 | |||
| Open | $107.83 | 52 Week Low | $55.00 | |||
| Day High | $109.64 | P/E | N/A | |||
| Day Low | $106.53 | EPS | $-0.56 | |||
| Volume | 1,488,908 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1133.00 -27.95 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1165.00 | 52 Week Low | $67.88 | |||
| Day High | $1169.99 | P/E | 262.27 | |||
| Day Low | $1132.81 | EPS | $4.32 | |||
| Volume | 2,437,568 | |||||
